3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP

Company: Zentalis Pharmaceuticals, Inc.
Filed: April 3, 2020
Period of Report: April 3, 2020
Accession Number: 0001387131-20-003711

View Document ↗ View on SEC.gov ↗